Our technology is crafted to provide our business associates with unique and innovative dosage forms, promoting product leadership and innovating health solutions for our patients. Our aim is to deliver exceptional benefits that are both distinctive and affordable.

Pellets

Multi-particulates offer precise control over drug release profiles, making them ideal for modified release forms. We specialize in manufacturing pellets with various release profiles (immediate, delayed, controlled, sustained, targeted, etc.), reducing dosage frequency, and minimizing side effects for enhanced patient convenience.+

Directly Compressible (DC) Granules

Directly compressible granules are crucial in tablet manufacturing, offering a seamless transition to the final product. With our cutting-edge technology, we specialize in producing these granules, particularly with modified release profiles. Any facility can easily compress them into tablets. Our advanced technological solutions empower PFI customers to address unmet medical needs in their markets

Taste Masking

Masking bitter tastes in oral drugs for special patient populations is a challenge. We’ve mastered taste masking without affecting drug efficacy or shelf life. Our products, including dry powders and orally disintegrating films, enhance patient compliance.

NIP Technology Platforms

Micro-Emulsion Coating Technology (MECT)

Used for solubilization of oil soluble drugs, liquids in the oil phase, and subsequently, micro emulsifying with aqueous phase containing polymer to coat over the substrate.

Pellet Cold Forming Technology (PCFT)

Used for heat sensitive material which either loses its potency or transform into another form for processing at normal temperatures.

Rapid Gelation Drug Release Technology (RGDRT)

It is used for release of drug in pseudo zero kinetics and is also an alternative to OROS® technology.

Matrix Pore Forming Tablet Technology (MAPOTAB)

Used for release of drug through pores into an aqueous media.